Detalhe da pesquisa
1.
A Phase II Study with Lead-In Safety Cohort of 5-Fluorouracil, Oxaliplatin, and Lapatinib in Combination with Radiation Therapy as Neoadjuvant Treatment for Patients with Localized HER2-Positive Esophagogastric Adenocarcinomas.
Oncologist
; 22(10): 1152-e98, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28765502
2.
A Phase-2 Trial of Single Agent Axitinib as Maintenance Therapy Following First-Line Treatment With Modified FOLFOX/Bevacizumab in Patients With Metastatic Colorectal Cancer.
Cancer Invest
; 35(6): 386-392, 2017 Jul 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28426267
3.
Impact of clinical pathways on treatment patterns and outcomes for patients with non-small-cell lung cancer: real-world evidence from a community oncology practice.
J Comp Eff Res
; 11(8): 609-619, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35546311
4.
A Phase II Open Label Study of Everolimus in Combination With Endocrine Therapy in Resistant Hormone Receptor-Positive HER2-Negative Advanced Breast Cancer.
Clin Breast Cancer
; 20(2): 89-97, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31932237
5.
Regorafenib Prior to Selective Internal Radiation Therapy Using 90Y-Resin Microspheres for Refractory Metastatic Colorectal Cancer Liver Metastases: Analysis of Safety, Dosimetry, and Molecular Markers.
Front Oncol
; 9: 624, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31355141